Survey of isoniazid preventive therapy in South Africa, 2011

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 7, 2012, Pages 903-907

  Chehab, Joel C ^a   Vilakazi Nhlapo, K ^b   Vranken, P ^a   Peters, A ^a   Klausner, J D ^a  

^a Centers for Disease Control and Prevention South Africa   (South Africa)

^b NATIONAL DEPARTMENT OF HEALTH   (South Africa)

Author keywords

Co infection; HIV; Integration; Prevention; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; ISONIAZID;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HEALTH CARE AVAILABILITY; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CENTER; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MIXED INFECTION; PATIENT COUNSELING; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SOUTH AFRICA; STAFF TRAINING;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; CROSS-SECTIONAL STUDIES; HIV INFECTIONS; HUMANS; ISONIAZID; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; SOUTH AFRICA; TUBERCULOSIS;

EID: 84862210348     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0722     Document Type: Article

References (27)

1. World Health Organization. Global tuberculosis control-epidemiology, strategy, fi nancing. WHO report 2009. WHO/HTM/TB/2009.411. Geneva, Switzerland: WHO, 2009.
2. Aït-Khaled N, Alarcon E, Bissell K, et al. Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues. Int J Tuberc Lung Dis 2009; 13: 927-935.
3. Grant A D, Charalambous S, Fielding K L, et al. Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study. JAMA 2005; 293: 2719-2725. (Pubitemid 40965083)
4. Whalen C C, Johnson J L, Okwera A, et al. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodefi ciency virus. Uganda-Case Western Reserve University Research Collaboration. N Engl J Med 1997; 337: 801-808. (Pubitemid 27391629)
5. Pape J, Jean S, Ho J, Hafner A, Johnson W. Effect of isoniazid prophylaxis of the incidence of active tuberculosis and progression of HIV infection. Lancet 1993; 342: 268-272. (Pubitemid 23224420)
6. Halsey N A, Coberly J S, Desormeaux J, et al. Randomized trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Lancet 1998; 351: 786-792. (Pubitemid 28112340)
7. Wilkinson D. Drugs for preventing tuberculosis in HIV-infected persons. Cochrane Database Syst Rev 2000; 4: CD000171.
8. Woldehana S, Volmink J. Treatment of latent tuberculosis infection in HIV-infected persons. Cochrane Database Syst Rev 2004; 1: CD000171.
9. Golub J E, Saraceni V, Cavalcante S C, et al. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS 2007; 21: 1441-1448. (Pubitemid 46988004)
10. World Health Organization, Stop TB Partnership. The Global Plan to Stop TB 2011-2015: transforming the fi ght towards elimination of tuberculosis. Geneva, Switzerland: WHO, 2010.
11. World Health Organization. Guidelines for intensifi ed tuberculosis case fi nding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva, Switzerland: WHO, 2010.
12. Republic of South Africa National Department of Health. The guidelines for tuberculosis preventive therapy among HIV infected individuals. IPT guidelines 2010. Pretoria, South Africa: NDOH, 2010.
13. Republic of South Africa National Department of Health. The National Tuberculosis Control Programme. National tuberculosis policy guidelines 2009. Pretoria, South Africa: NDOH, 2010.
14. Eldred L J, Churchyard G, Durovni B, et al. Isoniazid preventive therapy for HIV-infected people: evidence to support implementation. AIDS 2010; 24 (Suppl 5): S1-S3.
15. Charalambous S, Grant A D, Innes C, et al. Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme. AIDS 2010; 24 (Suppl 5): S5-S13.
16. Durovni B, Cavalcante S C, Saraceni V, et al. The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB-HIV in Rio (THRio) Study. AIDS 2010; 24 (Suppl 5): S49-S56.
17. Getahun H, Granich R, Sculier D, et al. Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions. AIDS 2010; 24 (Suppl 5): S57-S65.
18. Dodd L E, Wilkinson R J. Isoniazid preventive therapy in HIV infection. Lancet 2011; 377: 1548-1549.
19. Reid M J A, Shah N S. Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. Lancet Infect Dis 2009; 9: 173-184.
20. Shishana O, Rehle T, Simbayi L C, et al., and the SABSSM III Implementation Team. South African national HIV prevalence, incidence, behaviour and communication survey 2008: a turning tide among teenagers? Cape Town, South Africa: HSRC Press, 2009.
21. World Health Organization, Joint United Nations Programme on HIV/AIDS, United Nations International Children's Emergency Fund. Towards universal access. Scaling up priority HIV/ AIDS interventions in the health sector. Progress report 2009. Geneva, Switzerland: WHO, 2009.
22. Lester R, Hamilton R, Charalambous S, et al. Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study. AIDS 2010; 24 (Suppl 5): S45-S48.
23. Date A A, Marco V, Granich R, Mazuwa B, Fox M Y, Gilks C. Implementation of cotrimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV. Bull World O rgan 2010; 88: 253-259.
24. Republic of South Africa Department of Health. Draft tuberculosis strategic plan for South Africa, 2007-2011. Pretoria, South Africa: DOH, 2011. http://www.doh.gov.za/tb/docs/stratplan/2007-2011/tb/index.html Accessed March 2012.
25. Harries A D, Zachariah R, Corbett E L, et al. The HIV-associated tuberculosis epidemic-when will we act? Lancet 2010; 375:1906-1919.
26. Churchyard G J, Scano F, Grant A D, Chaisson R E. Tuberculosis preventive therapy in the era of HIV infection: overview and research priorities. J Infect Dis 2007; 196 (Suppl 1): S52-S62. (Pubitemid 47206085)
27. Sanne I, Orrell C, Fox M, et al. Nurse management is not inferior to doctor management of antiretroviral patients: the CIPRA South Africa randomized trial. Lancet 2010; 376: 33-40.